AML - The Spotlight Journal

Featured

AbbVie Showcases Groundbreaking Blood Cancer Advances at ASH 2025: Novel Therapies Featured

December 3, 2025December 3, 2025 Delilah Ford0Tagged 2025, AbbVie, acute myeloid leukemia, ADC, advances, AML, ASH, blood cancer, epcoritamab, FL, follicular lymphoma, hematology, leukemia, lymphoma, multiple myeloma, myeloma, novel therapies, pipeline, pivekimab

AbbVie presented significant new data at the 2025 American Society of Hematology (ASH) Congress, highlighting their ongoing commitment to combating **AbbVie Blood Cancer**. The congress showcases the latest advances in […]